Successful Changes in the Pharmaceutical Industry

by Georgi BoyanovBUS 449a: Change Management

Statistics History Medicinal recipes Vaccines Innovation Mergers & Acquisitions

Talking points

http://www.google.com/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&cad=rja&uact=8&ved=0CAcQjRxqFQoTCNn44fTbh8gCFQxrFAod7AUHwA&url=http%3A%2F%2Fwww.wonderfultemplates.xyz%2Fus-flag%2F&psig=AFQjCNGEzxIlJ2iEcUIxUz7RGpxcVAvFgA&ust=1442910773944629

Revenues: $980 billion annually; The Big Three:

◦ Novartis (Swiss) - $46 billion revenue, $9.3 billion R&D◦ Pfizer (US) - $44.5 billion revenue, $7.1 billion R&D◦ Roche (Swiss) - $40 billion revenue, $8.6 billion R&D

US Market – 40% of the global market;

Development of a new drug:◦ From research to market – 13-16 years;◦ Costs between $1-11 billion, average is $4 billion

Statistics

Mid 19th century – from botanical remedies to manufacturing

Historical Changes

Beginning of 20th century:◦ Regulation – from independent small scale

manufacturers to controlled premarket approvals Recipes:

Historical Changes

Beginning of the 20th century:◦ Pneumonia◦ Tuberculosis◦ Infections

Penicillin - 1928 Vaccines – prevention rather than control

◦ Polio◦ Tuberculosis◦ Measles

Treatment

Example: Birth Control

The change towards “Personalized Medicine”:◦ The right treatment for the right person at the

right time…

Vertical integration

Supporting regulations

Business & Innovation

The EndThank you for your attention!